ResearchGuide Logo

Chat support

Advanced search ?

Discover the optimal journal based on multiple criteria or locate authors along with their published articles and the corresponding journals.

Publisher

* You can search a publisher or tap the name directly

Subject Area

* You can search a subject area or tap the name directly

Open Acess

Quartille





Cancer Nanotechnology

VERIFIED JOURNAL
You want to contribute ? Login first and send us the Journal infos you think is correct.
We would be pleased to have your collaboration

This journal is included in the ResearchGuide whitelist of reputable titles. Learn more here.

JOURNAL INFORMATION
Publisher Springer Science + Business Media
Open Access YES
Quartile Q1
Citation Count 267
P-ISSN 1868-6958
E-ISSN 1868-6966
Categories Biomedical Engineering, Pharmaceutical Science, Physical and Theoretical Chemistry, Oncology
Area Chemistry, Engineering, Medicine, Pharmacology, Toxicology and Pharmaceutics
Region Northern America
Country United States
Summary

  1. Cancer Nanotechnology is published by Springer Science + Business Media
  2. It is an oppen access journal
  3. The Subject Area : Chemistry; Engineering; Medicine; Pharmacology, Toxicology and Pharmaceutics

Latest Articles published

Last updated: 17/11/2024

Unveiling the therapeutic potential of anthocyanin/cisplatin-loaded chitosan nanoparticles against breast and liver cancers


Last updated: 10/11/2024

Near-infrared modulated photothermal/nanozymatic dual-modal strategy for combating cancer via molybdenum selenide nanourchins


Last updated: 28/10/2024

Novel plasmon-coupled Ag/Ag2O nano-particles to downregulate β-catenin pathway in triple negative breast cancer


Last updated: 28/10/2024

Delivery of IL2RG mRNA via nanoparticles to enhance CD8+ T cell promotes anti-tumor effects against late-stage triple-negative breast cancer


Last updated: 20/10/2024

Antineoplastic activity of Artemisia annua bio-united Fe3O4/CeO2 on 4T1 breast cancer cells: in vivo and in vitro


Last updated: 06/10/2024

Inhibition of malate dehydrogenase via nanoselenium coupling with nanocellulose composite in MCF-7 breast carcinoma cells


Last updated: 29/09/2024

Evaluation of the performance of Fe3O4/MnO2@doxorubicin hybrid nanozymes on multicellular structure and their therapeutic management to limit the growth of human breast cancer cells


Last updated: 22/09/2024

A biocompatible nanoformulation of curcumin analogue and curd exosomes targeting EphA2 signalling cascade in head and neck cancer


Last updated: 15/09/2024

Correction: Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20)


Last updated: 15/09/2024

Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20)